Related references
Note: Only part of the references are listed.Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion
Seema Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
S. Singh et al.
BRITISH JOURNAL OF CANCER (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Host CXCR2-Dependent Regulation of Melanoma Growth, Angiogenesis, and Experimental Lung Metastasis
Seema Singh et al.
CANCER RESEARCH (2009)
Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis
Seema Singh et al.
CLINICAL CANCER RESEARCH (2009)
CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer
Yoichi Matsuo et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
CXCL8/IL8 Stimulates Vascular Endothelial Growth Factor (VEGF) Expression and the Autocrine Activation of VEGFR2 in Endothelial Cells by Activating NFκB through the CBM (Carma3/Bcl10/Malt1) Complex
Daniel Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The good and the bad of chemokines/chemokine receptors in melanoma
Ann Richmond et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Tumor immunotherapy in melanoma - Strategies for overcoming mechanisms of resistance and escape
Maya Zigler et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2008)
The role of CXC chemokines and their receptors in cancer
Jo Vandercappellen et al.
CANCER LETTERS (2008)
Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead
Victor W. M. van Hinsbergh et al.
CARDIOVASCULAR RESEARCH (2008)
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation
Paul Proost et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Chemokines in tumor angiogenesis and metastasis
Seema Singh et al.
CANCER AND METASTASIS REVIEWS (2007)
Ultraviolet-B irradiation enhances melanoma cell motility via induction of autocrine interleukin 8 secretion
Carl Gebhardt et al.
EXPERIMENTAL DERMATOLOGY (2007)
Modulation of bcl-xL in tumor cells regulates angiogenesis through CXCL8 expression
Simona Giorgini et al.
MOLECULAR CANCER RESEARCH (2007)
A novel, orally active CXCR1/2 receptor antagonist, sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation
Richard W. Chapman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8
Vladislava O. Melnikova et al.
PIGMENT CELL RESEARCH (2006)
Role of CXCR2 in cigarette smoke-induced lung inflammation
TH Thatcher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2005)
Endothelin-1 induces CXCL1 and CXCL8 secretion in human melanoma cells
CR Mangahas et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury
R Bertini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CXC chemokines in angiogenesis of cancer
RM Strieter et al.
SEMINARS IN CANCER BIOLOGY (2004)
IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis
AH Li et al.
JOURNAL OF IMMUNOLOGY (2003)
Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype
ML Varney et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
Interleukin-8 and human cancer biology
KP Xie
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
17β-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production
N Kanda et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
CL Addison et al.
JOURNAL OF IMMUNOLOGY (2000)
Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells
R Salcedo et al.
FASEB JOURNAL (2000)
Matrix metalloproteinases: multifunctional contributors to tumor progression
LJ McCawley et al.
MOLECULAR MEDICINE TODAY (2000)